Skip to main content
Immunology logoLink to Immunology
. 1998 Nov;95(3):370–376. doi: 10.1046/j.1365-2567.1998.00606.x

Immunosuppressant deoxyspergualin induces apoptotic cell death in dividing cells.

C Odaka 1, E Toyoda 1, K Nemoto 1
PMCID: PMC1364402  PMID: 9824499

Abstract

Deoxyspergualin (DSG) has been found to have an antitumour and immunosuppressive activity. However, the precise mechanism of action of DSG has not been clarified. We have used its analogue, methyldeoxyspergualin (MeDSG) for in vitro culture studies of DSG since it shows good stability in aqueous solution and retains strong immunosuppressive activity. In the present study, we found that MeDSG inhibited proliferation of rapidly dividing murine T-cell hybridomas, resulting in cell death. The cell death was accompanied by chromatin condensation and DNA cleavage at the linker regions between nucleosomes. Furthermore, MeDSG induced a reduction in mitochondrial transmembrane potential. When murine thymocytes were treated with MeDSG for 48 hr, a slight increase of DNA fragmentation was constantly observed, and selective depletion of CD4- CD8- cells was noticed. In contrast, CD4+ CD8+ cells were hardly affected. Moreover, splenic T-cells are resistant to MeDSG-induced apoptosis, as evaluated by measuring DNA cleavage. Our findings may account for the immunosuppressive and antitumour properties of DSG which were described in a number of previous studies.

Full text

PDF
370

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alegre M. L., Sattar H. A., Herold K. C., Smith J., Tepper M. A., Bluestone J. A. Prevention of the humoral response induced by an anti-CD3 monoclonal antibody by deoxyspergualin in a murine model. Transplantation. 1994 Jun 27;57(12):1786–1794. [PubMed] [Google Scholar]
  2. Amemiya H., Suzuki S., Ota K., Takahashi K., Sonoda T., Ishibashi M., Omoto R., Koyama F., Orita K., Takagi H. Multicentre clinical trial of antirejection pulse therapy with deoxyspergualin in kidney transplant patients. Int J Clin Pharmacol Res. 1991;11(4):175–182. [PubMed] [Google Scholar]
  3. Dickneite G., Schorlemmer H. U., Sedlacek H. H. Decrease of mononuclear phagocyte cell functions and prolongation of graft survival in experimental transplantation by (+/-)-15-deoxyspergualin. Int J Immunopharmacol. 1987;9(5):559–565. doi: 10.1016/0192-0561(87)90123-8. [DOI] [PubMed] [Google Scholar]
  4. Fujii H., Takada T., Nemoto K., Abe F., Fujii A., Takeuchi T. In vitro immunosuppressive properties of spergualins to murine T cell response. J Antibiot (Tokyo) 1989 May;42(5):788–794. doi: 10.7164/antibiotics.42.788. [DOI] [PubMed] [Google Scholar]
  5. Fujii H., Takada T., Nemoto K., Abe F., Fujii A., Talmadge J. E., Takeuchi T. Deoxyspergualin, a novel immunosuppressant, markedly inhibits human mixed lymphocyte reaction and cytotoxic T-lymphocyte activity in vitro. Int J Immunopharmacol. 1992 May;14(4):731–737. doi: 10.1016/0192-0561(92)90136-9. [DOI] [PubMed] [Google Scholar]
  6. Hoeger P. H., Tepper M. A., Faith A., Higgins J. A., Lamb J. R., Geha R. S. Immunosuppressant deoxyspergualin inhibits antigen processing in monocytes. J Immunol. 1994 Nov 1;153(9):3908–3916. [PubMed] [Google Scholar]
  7. Jiang H., Takahara S., Takano Y., Machida M., Iwasaki A., Kokado Y., Kameoka H., Moutabarrik A., Ishibashi M., Sonoda T. In vitro immunosuppressive effect of deoxymethylspergualin. Transplant Proc. 1990 Aug;22(4):1633–1637. [PubMed] [Google Scholar]
  8. Kerr P. G., Atkins R. C. The effects of deoxyspergualin on lymphocytes and monocytes in vivo and in vitro. Transplantation. 1989 Dec;48(6):1048–1052. doi: 10.1097/00007890-198912000-00031. [DOI] [PubMed] [Google Scholar]
  9. Kunimoto S., Miura K., Iinuma H., Takeuchi T., Umezawa H. Cytotoxicity of spergualin and amine oxidase activity in medium. J Antibiot (Tokyo) 1985 Jul;38(7):899–903. doi: 10.7164/antibiotics.38.899. [DOI] [PubMed] [Google Scholar]
  10. Leventhal J. R., Flores H. C., Gruber S. A., Figueroa J., Platt J. L., Manivel J. C., Bach F. H., Matas A. J., Bolman R. M., 3rd Evidence that 15-deoxyspergualin inhibits natural antibody production but fails to prevent hyperacute rejection in a discordant xenograft model. Transplantation. 1992 Jul;54(1):26–31. doi: 10.1097/00007890-199207000-00004. [DOI] [PubMed] [Google Scholar]
  11. Metcalfe S., Milner J., Richards F. M. FK 506 and cyclosporine A: early effects on activation and gene induction in mouse spleen cells. Transplant Proc. 1990 Aug;22(4):1547–1548. [PubMed] [Google Scholar]
  12. Morikawa K., Oseko F., Morikawa S. The suppressive effect of deoxyspergualin on the differentiation of human B lymphocytes maturing into immunoglobulin-producing cells. Transplantation. 1992 Sep;54(3):526–531. doi: 10.1097/00007890-199209000-00026. [DOI] [PubMed] [Google Scholar]
  13. Nadler S. G., Tepper M. A., Schacter B., Mazzucco C. E. Interaction of the immunosuppressant deoxyspergualin with a member of the Hsp70 family of heat shock proteins. Science. 1992 Oct 16;258(5081):484–486. doi: 10.1126/science.1411548. [DOI] [PubMed] [Google Scholar]
  14. Nemoto K., Abe F., Nakamura T., Ishizuka M., Takeuchi T., Umezawa H. Blastogenic responses and the release of interleukins 1 and 2 by spleen cells obtained from rat skin allograft recipients administered with 15-deoxyspergualin. J Antibiot (Tokyo) 1987 Jul;40(7):1062–1064. doi: 10.7164/antibiotics.40.1062. [DOI] [PubMed] [Google Scholar]
  15. Nemoto K., Hayashi M., Ito J., Abe F., Takita T., Nakamura T., Takeuchi T., Umezawa H. Effect of spergualin in autoimmune disease mice. J Antibiot (Tokyo) 1987 Oct;40(10):1448–1451. doi: 10.7164/antibiotics.40.1448. [DOI] [PubMed] [Google Scholar]
  16. Nemoto K., Hayashi M., Ito J., Sugawara Y., Mae T., Fujii H., Abe F., Fujii A., Takeuchi T. Deoxyspergualin in lethal murine graft-versus-host disease. Transplantation. 1991 Mar;51(3):712–715. doi: 10.1097/00007890-199103000-00032. [DOI] [PubMed] [Google Scholar]
  17. Nemoto K., Sugawara Y., Mae T., Hayashi M., Abe F., Fujii A., Takeuchi T. Therapeutic activity of deoxyspergualin in comparison with cyclosporin A, and its combined use with cyclosporin A and prednisolone in highly allogeneic skin transplantation in the rat. Agents Actions. 1992 Jul;36(3-4):306–311. [PubMed] [Google Scholar]
  18. Nishimura K., Tokunaga T. Mechanism of action of 15-deoxyspergualin. I. Suppressive effect on the induction of alloreactive secondary cytotoxic T lymphocytes in vivo and in vitro. Immunology. 1989 Sep;68(1):66–71. [PMC free article] [PubMed] [Google Scholar]
  19. Odaka C., Kizaki H., Tadakuma T. T cell receptor-mediated DNA fragmentation and cell death in T cell hybridomas. J Immunol. 1990 Mar 15;144(6):2096–2101. [PubMed] [Google Scholar]
  20. Ohlman S., Gannedahl G., Tydén G., Tufveson G., Groth C. G. Treatment of renal transplant rejection with 15-deoxyspergualin--a dose-finding study in man. Transplant Proc. 1992 Feb;24(1):318–320. [PubMed] [Google Scholar]
  21. Petit P. X., O'Connor J. E., Grunwald D., Brown S. C. Analysis of the membrane potential of rat- and mouse-liver mitochondria by flow cytometry and possible applications. Eur J Biochem. 1990 Dec 12;194(2):389–397. doi: 10.1111/j.1432-1033.1990.tb15632.x. [DOI] [PubMed] [Google Scholar]
  22. Reichenspurner H., Hildebrandt A., Human P. A., Boehm D. H., Rose A. G., Odell J. A., Reichart B., Schorlemmer H. U. 15-Deoxyspergualin for induction of graft nonreactivity after cardiac and renal allotransplantation in primates. Transplantation. 1990 Aug;50(2):181–185. doi: 10.1097/00007890-199008000-00001. [DOI] [PubMed] [Google Scholar]
  23. Stefanelli C., Bonavita F., Stanic' I., Farruggia G., Falcieri E., Robuffo I., Pignatti C., Muscari C., Rossoni C., Guarnieri C. ATP depletion inhibits glucocorticoid-induced thymocyte apoptosis. Biochem J. 1997 Mar 15;322(Pt 3):909–917. doi: 10.1042/bj3220909. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Tadakuma T., Kizaki H., Odaka C., Kubota R., Ishimura Y., Yagita H., Okumura K. CD4+CD8+ thymocytes are susceptible to DNA fragmentation induced by phorbol ester, calcium ionophore and anti-CD3 antibody. Eur J Immunol. 1990 Apr;20(4):779–784. doi: 10.1002/eji.1830200411. [DOI] [PubMed] [Google Scholar]
  25. Takahara S., Jiang H., Takano Y., Kokado Y., Ishibashi M., Okuyama A., Sonoda T. The in vitro immunosuppressive effect of deoxymethylspergualin in man as compared with FK506 and cyclosporine. Transplantation. 1992 Apr;53(4):914–918. doi: 10.1097/00007890-199204000-00037. [DOI] [PubMed] [Google Scholar]
  26. Takahara S., Jiang H., Takano Y., Kokado Y., Kameoka H., Moutabarrik A., Ishibashi M., Okuyama A., Sonoda T. Experience gained from the administration of 15-deoxyspergualin for recurrent graft rejection in kidney transplant recipients. Transplant Proc. 1992 Aug;24(4):1377–1380. [PubMed] [Google Scholar]
  27. Takahashi K., Ota K., Tanabe K., Oba S., Teraoka S., Toma H., Agishi T., Kawaguchi H., Ito K. Effect of a novel immunosuppressive agent, deoxyspergualin, on rejection in kidney transplant recipients. Transplant Proc. 1990 Aug;22(4):1606–1612. [PubMed] [Google Scholar]
  28. Takano Y., Takahara S., Jiang H., Kokado Y., Kameoka H., Moutabarrik A., Ishibashi M., Okuyama A. Immunosuppressive mechanism of action of deoxymethylspergualin--a human in vitro assay. Transplant Proc. 1992 Aug;24(4):1372–1374. [PubMed] [Google Scholar]
  29. Takasu S., Sakagami K., Morisaki F., Kawamura T., Haisa M., Oiwa T., Inagaki M., Hasuoka H., Kurozumi Y., Orita K. Immunosuppressive mechanism of 15-deoxyspergualin on sinusoidal lining cells in swine liver transplantation: suppression of MHC class II antigens and interleukin-1 production. J Surg Res. 1991 Aug;51(2):165–169. doi: 10.1016/0022-4804(91)90089-5. [DOI] [PubMed] [Google Scholar]
  30. Takeuchi T., Iinuma H., Kunimoto S., Masuda T., Ishizuka M., Takeuchi M., Hamada M., Naganawa H., Kondo S., Umezawa H. A new antitumor antibiotic, spergualin: isolation and antitumor activity. J Antibiot (Tokyo) 1981 Dec;34(12):1619–1621. doi: 10.7164/antibiotics.34.1619. [DOI] [PubMed] [Google Scholar]
  31. Tepper M. A., Nadler S., Mazzucco C., Singh C., Kelley S. L. 15-Deoxyspergualin, a novel immunosuppressive drug: studies of the mechanism of action. Ann N Y Acad Sci. 1993 Jun 23;685:136–147. doi: 10.1111/j.1749-6632.1993.tb35860.x. [DOI] [PubMed] [Google Scholar]
  32. Tepper M. A., Petty B., Bursuker I., Pasternak R. D., Cleaveland J., Spitalny G. L., Schacter B. Inhibition of antibody production by the immunosuppressive agent, 15-deoxyspergualin. Transplant Proc. 1991 Feb;23(1 Pt 1):328–331. [PubMed] [Google Scholar]
  33. Umezawa H., Ishizuka M., Takeuchi T., Abe F., Nemoto K., Shibuya K., Nakamura T. Suppression of tissue graft rejection by spergualin. J Antibiot (Tokyo) 1985 Feb;38(2):283–284. doi: 10.7164/antibiotics.38.283. [DOI] [PubMed] [Google Scholar]
  34. Vayssiere J. L., Petit P. X., Risler Y., Mignotte B. Commitment to apoptosis is associated with changes in mitochondrial biogenesis and activity in cell lines conditionally immortalized with simian virus 40. Proc Natl Acad Sci U S A. 1994 Nov 22;91(24):11752–11756. doi: 10.1073/pnas.91.24.11752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Waaga A. M., Krzymański M., Ulrichs K., Treumer J., Oko A., Müller-Ruchholtz W. In vitro analysis of the mode of action of the immuno-suppressive drug 15-deoxyspergualin. Arch Immunol Ther Exp (Warsz) 1996;44(2-3):155–163. [PubMed] [Google Scholar]
  36. Wang B., Benoist C., Mathis D. The immunosuppressant 15-deoxyspergualin [correction of 1,5-deoxyspergualin] reveals commonality between preT and preB cell differentiation. J Exp Med. 1996 Jun 1;183(6):2427–2436. doi: 10.1084/jem.183.6.2427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Wolvetang E. J., Johnson K. L., Krauer K., Ralph S. J., Linnane A. W. Mitochondrial respiratory chain inhibitors induce apoptosis. FEBS Lett. 1994 Feb 14;339(1-2):40–44. doi: 10.1016/0014-5793(94)80380-3. [DOI] [PubMed] [Google Scholar]
  38. Wyllie A. H. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature. 1980 Apr 10;284(5756):555–556. doi: 10.1038/284555a0. [DOI] [PubMed] [Google Scholar]
  39. Zhu X., Imamura M., Tanaka J., Han C. W., Hashino S., Imai K., Asano M., Nakane A., Minagawa T., Kobayashi M. Effects of 15-deoxyspergualin in vitro and in vivo on cytokine gene expression. Transplantation. 1994 Nov 27;58(10):1104–1109. [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES